DrugDashboards

Tacrolimus

Tacrolimus Ointment 0.1% · TACROLIMUS 1 mg/g · Ointment · Topical · Encube Ethicals, Inc.

NDC 21922-0011-07 · 1 TUBE in 1 CARTON / 60 g in 1 TUBE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price is down 10% over the past year, to $0.9192 per gram. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00$1.50Feb 2024Sep 2026$0.9192
32 price points · per GMSource: CMS NADAC

Medicaid spend (2025)

$822,262
12,261 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for tacrolimus (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA212387
TE code
BX
Approval date
Oct 10, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Tacrolimus Ointment 0.1% (Ointment)

LabelerStrengthFirst seenLast seen
Encube Ethicals, Inc.TACROLIMUS 1 mg/gJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Tacrolimus — NDC 21922-0011-07," retrieved September 3, 2026, https://drugdashboards.com/drug/21922001107.

Free to cite with attribution — see how the data is put together.